ClinicalTrialsFinder

Coronavirus Disease (COVID-19) Clinical Trials in Ansan-si, Kyonggi-do

1 recruitingAnsan-si, Kyonggi-do, South Korea

Showing 1–1 of 1 trials

Recruiting
Phase 3

A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)

Coronavirus Disease (COVID-19)
Merck Sharp & Dohme LLC3,082 enrolled222 locationsNCT06667700